A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/47 (2006.01)
Patent
CA 2262637
The use of hyaluronidase in the manufacturing of a drug for the treatment of conditions of interstitial edema in connection with organ grafting associated with an increased local content of hyaluronan in the connective tissue of a mammal. The drug comprises hyaluronidase in an amount giving a daily dosage of from 1 to 100,000 IU/kg body weight when given locally or systemically to a mammal. A method of treating conditions of interstitial edema in connection with organ grafting associated with an increased local synthesis of hyaluronan by systemic or local treatment with a pharmaceutical comprising hyaluronidase.
Utilisation de hyaluronidase dans la préparation d'un médicament servant à traiter un état d'oedème interstitiel provenant d'une greffe d'organe associée à une augmentation de la teneur locale en hyaluronane dans le tissu conjonctif d'un mammifère. Ce médicament contient hyaluronidase selon une quantité permettant un dosage journalier de 1 à 100 000 IU/kg de poids du corps quand on l'administre au mammifère de façon locale ou systémique. Procédé servant à traiter des états d'oedème interstitiel provenant d'une greffe d'organe associée à une augmentation de la synthèse locale de hyaluronane au moyen d'un traitement local ou systémique au moyen d'un médicament pharmaceutique contenant hyaluronidase.
Hallgren Roger
Johnsson Cecilia
Tufveson Gunnar
Wahlberg Jan
Applet Mbj Ab
Hallgren Roger
Johnsson Cecilia
Smart & Biggar
Tufveson Gunnar
LandOfFree
Use of hyaluronidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hyaluronidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hyaluronidase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1719255